Web Analytics

3 Latest Announced Rounds

  • $10,600,000
    Pre-Seed

    5 Investors

    Technology, Information and Internet
    Jun 6th, 2025
  • $13,702,071
    Series A

    3 Investors

    Insurance
    Jun 6th, 2025
  • $15,000,000
    Unknown

    1 Investors

    Biotechnology Research
    Jun 6th, 2025
$863.23M Raised in 46 Funding Rounds in the past 7 Days - View All

Funding Round Profile

DiogenX

start up
France - Marseille
  • 11/05/2023
  • Series A
  • $30,056,125

DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
DiogenX is headquartered in Marseille, with labs in Nice (France).


Related People

Benjamin CHARLESFounder

Benjamin CHARLES France - Marseille, Provence-Alpes-Côte d'Azur

N/A